{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "KDM5B",
      "chemoresistance",
      "combination therapy",
      "tumor"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "38014925",
  "DateCompleted": {
    "Year": "2024",
    "Month": "01",
    "Day": "18"
  },
  "DateRevised": {
    "Year": "2024",
    "Month": "01",
    "Day": "18"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2023",
        "Month": "11",
        "Day": "28"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1002/jbt.23587"
    ],
    "Journal": {
      "ISSN": "1099-0461",
      "JournalIssue": {
        "Volume": "38",
        "Issue": "1",
        "PubDate": {
          "Year": "2024",
          "Month": "Jan"
        }
      },
      "Title": "Journal of biochemical and molecular toxicology",
      "ISOAbbreviation": "J Biochem Mol Toxicol"
    },
    "ArticleTitle": "Lysine demethylase 5B (KDM5B): A key regulator of cancer drug resistance.",
    "Pagination": {
      "StartPage": "e23587",
      "MedlinePgn": "e23587"
    },
    "Abstract": {
      "AbstractText": [
        "Chemoresistance, a roadblock in the chemotherapy process, has been impeding its effective treatment. KDM5B, a member of the histone demethylase family, has been crucial in the emergence and growth of malignancies. More significantly, KDM5B has recently been linked closely to cancer's resistance to chemotherapy. In this review, we explain the biological properties of KDM5B, its function in the emergence and evolution of cancer treatment resistance, and our hopes for future drug resistance-busting combinations involving KDM5B and related targets or medications."
      ],
      "CopyrightInformation": "\u00a9 2023 Wiley Periodicals LLC."
    },
    "AuthorList": [
      {
        "Identifier": [
          "0000-0002-5770-6237"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "College of Basic Medicine and Forensic Medicine, Henan University of Science and Technology, Luoyang, China."
          }
        ],
        "LastName": "Cao",
        "ForeName": "Yaquan",
        "Initials": "Y"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China."
          }
        ],
        "LastName": "Wu",
        "ForeName": "Chunli",
        "Initials": "C"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "State Key Laboratory of Esophageal Cancer Prevention and Treatment, Key Laboratory of Advanced Pharmaceutical Technology, Ministry of Education of China, School of Pharmaceutical Science and Institute of Pharmaceutical Science, Zhengzhou University, Zhengzhou, Henan, China."
          },
          {
            "Identifier": [],
            "Affiliation": "Key Laboratory of Cardio-Cerebrovascular Drug, China Meheco Topfond Pharmaceutical Company, Zhumadian, China."
          }
        ],
        "LastName": "Ma",
        "ForeName": "Liying",
        "Initials": "L"
      }
    ],
    "GrantList": [
      {
        "GrantID": "2020 M672249",
        "Agency": "The China Postdoctoral Science Foundation",
        "Country": ""
      },
      {
        "GrantID": "2017YFD0501400",
        "Agency": "National Key Research and Development Program of China",
        "Country": ""
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "J Biochem Mol Toxicol",
    "NlmUniqueID": "9717231",
    "ISSNLinking": "1095-6670"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "K3Z4F929H6",
      "NameOfSubstance": "Lysine"
    },
    {
      "RegistryNumber": "EC 1.14.11.-",
      "NameOfSubstance": "KDM5B protein, human"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Nuclear Proteins"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Repressor Proteins"
    },
    {
      "RegistryNumber": "EC 1.14.11.-",
      "NameOfSubstance": "Jumonji Domain-Containing Histone Demethylases"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Lysine"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Drug Resistance, Neoplasm"
    },
    {
      "QualifierName": [
        "drug therapy"
      ],
      "DescriptorName": "Neoplasms"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Nuclear Proteins"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Repressor Proteins"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Jumonji Domain-Containing Histone Demethylases"
    }
  ]
}